The CDK 7 Inhibitors Market represents a cutting-edge and rapidly developing field within cancer treatment therapeutics. Cyclin-dependent kinase 7 (CDK 7) functions as a vital enzyme with twin responsibilities in controlling cell cycle progression and transcriptional activity, positioning it as an attractive candidate for oncology interventions. As pharmaceutical investigation advances in...